275 related articles for article (PubMed ID: 22392456)
1. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
2. Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies.
Hansen RA; Dusetzina SB; Ellis AR; Stürmer T; Farley JF; Gaynes BN
Gen Hosp Psychiatry; 2012; 34(2):192-200. PubMed ID: 22079151
[TBL] [Abstract][Full Text] [Related]
3. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
4. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
5. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
[TBL] [Abstract][Full Text] [Related]
6. Limitations in efficacy of antidepressant monotherapy.
Rush AJ
J Clin Psychiatry; 2007; 68 Suppl 10():8-10. PubMed ID: 17900203
[TBL] [Abstract][Full Text] [Related]
7. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Perlis RH; Uher R; Perroud N; Fava M
J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
[TBL] [Abstract][Full Text] [Related]
8. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
Bech P; Fava M; Trivedi MH; Wisniewski SR; Rush AJ
Acta Psychiatr Scand; 2012 Apr; 125(4):342-8. PubMed ID: 22077211
[TBL] [Abstract][Full Text] [Related]
9. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
Landowski J
Psychiatr Pol; 2000; 34(3 Suppl):1-8. PubMed ID: 11055187
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
[TBL] [Abstract][Full Text] [Related]
11. Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial.
Olgiati P; Bajo E; Bigelli M; Montgomery S; Serretti A;
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1739-46. PubMed ID: 24075716
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and drug induced side effects in early versus late antidepressant responders.
Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
[TBL] [Abstract][Full Text] [Related]
13. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.
Saragoussi D; Chollet J; Bineau S; Chalem Y; Milea D
Int J Clin Pract; 2012 Nov; 66(11):1079-87. PubMed ID: 23067031
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
16. Diurnal mood variation in outpatients with major depressive disorder.
Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
[TBL] [Abstract][Full Text] [Related]
17. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
18. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
19. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
[TBL] [Abstract][Full Text] [Related]
20. Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Souery D; Serretti A; Calati R; Oswald P; Massat I; Konstantinidis A; Linotte S; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Zohar J; Mendlewicz J
J Clin Psychopharmacol; 2011 Aug; 31(4):512-6. PubMed ID: 21694617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
